ArticleNeoplasia (New York, N.Y.)2025

Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging.

Gilberto S Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.